Biopharmaceutical Company Makes Headlines For Potential New Drug

The Future of Postoperative Pain: Trevena's Oliceridine.

As an investor it's important to stay updated with major news. Get real-time stock market alerts, news, and research by creating an account here.

The world of medicine is constantly evolving, and one company at the forefront of this evolution is Trevena, Inc. (NASDAQ: $TRVN). A biopharmaceutical company with a focus on developing innovative therapies, Tr…